Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Generic Fluticasone/Salmeterol vs Advair Diskus in Asthma
NCT02649478Completed
- Sponsor
- Roxane Laboratories
- Start
- Aug 2014
- Primary completion
- Nov 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial of salmeterol + fluticasone in asthma (3 arms), sponsored by Roxane Laboratories. Primary endpoints: Baseline-adjusted area under the serial FEV1-time curve from time 0 to 12 hours and Baseline-adjusted, pre-dose FEV1 at Day 30. Started Aug 2014; status: completed.
02
Drugs
salmeterol + fluticasone
03
Conditions
asthma
Beyond the preview
Go deeper on NCT02649478.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02649478.